Corkum MT - Search Results

1

Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.

Corkum MT, Buyyounouski MK, Chang AJ, Chung HT, Chung P, Cox BW, Crook JM, Davis BJ, Frank SJ, Henriquez I, Horwitz EM, Hoskin P, Hsu IC, Keyes M, King MT, Kollmeier MA, Krauss DJ, Kukielka AM, Morton G, Orio PF 3rd, Pieters BR, Potters L, Rossi PJ, Showalter TN, Solanki AA, Song D, Vanneste B, Vigneault E, Wojcieszek PA, Zelefsky MJ, Kamrava M. Corkum MT, et al. Radiother Oncol. 2023 Jul;184:109672. doi: 10.1016/j.radonc.2023.109672. Epub 2023 Apr 13. Radiother Oncol. 2023. PMID: 37059334

2

Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada.

Corkum MT, Morton G, Louie AV, Bauman GS, Mendez LC, Chin J, D'Souza DP, Dinniwell RE, Velker VM, Saskin R, Warner A, Rodrigues GB. Corkum MT, et al. Radiother Oncol. 2020 Nov;152:42-48. doi: 10.1016/j.radonc.2020.07.036. Epub 2020 Jul 24. Radiother Oncol. 2020. PMID: 32717361

3

Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trial.

Corkum M, Loblaw A, Hasan Y, Chung HT, Tseng CL, McGuffin M, Cheung P, Szumacher E, Liu S, Chu W, Zhang L, Mamedov A, Morton G. Corkum M, et al. Radiother Oncol. 2021 Mar;156:160-165. doi: 10.1016/j.radonc.2020.12.021. Epub 2021 Jan 4. Radiother Oncol. 2021. PMID: 33359269 Clinical Trial.

4

Radiation Oncologist Consultations Prior to Radical Prostatectomy: Disparities and Opportunities.

Corkum MT, Loblaw DA, Morton G, Louie AV, Glicksman R, Chin J, Kulkarni G, Dinniwell RE, Fisher B, Saskin R, Warner A, Rodrigues GB. Corkum MT, et al. J Urol. 2022 Jan;207(1):118-126. doi: 10.1097/JU.0000000000002187. Epub 2021 Aug 27. J Urol. 2022. PMID: 34445893

5

[No title available]

[No authors listed] [No authors listed] PMID: 34701055

6

[No title available]

[No authors listed] [No authors listed] PMID: 34701056

7

Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI.

Liu W, Fakir H, Randhawa G, Alfano R, Corkum M, Kassam Z, Rachinsky I, Chung HT, Chung P, Loblaw A, Morton G, Sexton T, Kapoor A, Ward A, Zukotynski K, Emmett L, Bauman G. Liu W, et al. Clin Transl Radiat Oncol. 2021 Nov 14;32:41-47. doi: 10.1016/j.ctro.2021.11.006. eCollection 2022 Jan. Clin Transl Radiat Oncol. 2021. PMID: 34841094 Free PMC article.

8

Ultrahypofractionated Radiotherapy for Localised Prostate Cancer: How Far Can We Go?

Corkum MT, Achard V, Morton G, Zilli T. Corkum MT, et al. Clin Oncol (R Coll Radiol). 2022 May;34(5):340-349. doi: 10.1016/j.clon.2021.12.006. Epub 2021 Dec 25. Clin Oncol (R Coll Radiol). 2022. PMID: 34961659 Free article. Review.

9

A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients.

Corkum MT, Morton G, Loblaw DA, Tseng CL, Murgic J, Ravi A, Davidson MTM, Wronski M, Haider M, Chung HT. Corkum MT, et al. Pract Radiat Oncol. 2022 Nov-Dec;12(6):e531-e537. doi: 10.1016/j.prro.2022.05.018. Epub 2022 Jun 17. Pract Radiat Oncol. 2022. PMID: 35718075

10

[No title available]

[No authors listed] [No authors listed] PMID: 37785424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results